VIGNA, Giovanni Battista
 Distribuzione geografica
Continente #
EU - Europa 5.021
NA - Nord America 4.920
AS - Asia 1.044
SA - Sud America 96
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 11.099
Nazione #
US - Stati Uniti d'America 4.891
IT - Italia 3.860
CN - Cina 482
UA - Ucraina 287
SG - Singapore 270
DE - Germania 250
TR - Turchia 233
GB - Regno Unito 154
FR - Francia 95
SE - Svezia 93
BR - Brasile 83
FI - Finlandia 80
PL - Polonia 53
NL - Olanda 30
CA - Canada 24
CH - Svizzera 22
BE - Belgio 19
IE - Irlanda 17
ID - Indonesia 16
RO - Romania 11
IN - India 7
RU - Federazione Russa 7
CZ - Repubblica Ceca 6
GR - Grecia 6
VN - Vietnam 6
CO - Colombia 5
JP - Giappone 5
LT - Lituania 5
ES - Italia 4
HK - Hong Kong 4
IR - Iran 4
MX - Messico 4
AU - Australia 3
EG - Egitto 3
EU - Europa 3
VE - Venezuela 3
AL - Albania 2
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
CV - Capo Verde 2
DK - Danimarca 2
DZ - Algeria 2
IQ - Iraq 2
KR - Corea 2
LU - Lussemburgo 2
NO - Norvegia 2
PK - Pakistan 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
TZ - Tanzania 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 11.099
Città #
Fairfield 608
Woodbridge 555
Houston 368
Jacksonville 344
Ann Arbor 326
Ashburn 296
Santa Clara 283
Chandler 273
Milan 268
Seattle 261
Rome 250
Cambridge 216
Wilmington 201
Singapore 188
Izmir 153
Beijing 112
Nanjing 96
Naples 94
Princeton 79
Bremen 77
Dearborn 57
Boardman 55
Turin 53
New York 51
Padova 49
Ferrara 46
Bologna 43
Catania 42
Bari 40
Palermo 38
Warsaw 37
San Diego 36
Shanghai 33
Florence 31
Los Angeles 31
Nanchang 31
Napoli 30
Shenyang 30
Genoa 28
Verona 23
Hebei 22
Jiaxing 22
Addison 19
London 19
Mountain View 19
Redwood City 19
Ancona 18
Brussels 18
Dallas 18
Parma 17
Tianjin 17
Changsha 16
Falls Church 16
Jakarta 16
Southend 14
Toronto 14
Caserta 13
Munich 12
Perugia 12
Norwalk 11
Taranto 11
Trieste 11
Cesena 10
Kunming 10
Nocera Inferiore 10
Torino 10
Andover 9
Auburn Hills 9
Des Moines 9
Guangzhou 9
Livorno 9
Nürnberg 9
Pettorazza Grimani 9
Pisa 9
Siena 9
Venice 9
Zhengzhou 9
Brescia 8
Genova 8
Messina 8
Reggio Emilia 8
Salerno 8
São Paulo 8
Altopascio 7
Cagliari 7
Helsinki 7
Lappeenranta 7
Ningbo 7
Nuremberg 7
Ottawa 7
Portici 7
Trento 7
Vicenza 7
Arad 6
Castelfranco Veneto 6
Imola 6
Jinan 6
Lecce 6
Lido di Fermo 6
Monza 6
Totale 6.485
Nome #
Tessuto adiposo e infiammazione sistemica. 2.458
Sindrome metabolica e infiammazione sistemica 1.278
Sindrome metabolica e steatosi epatica: rapporti, meccanismi e determinanti. 230
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study 169
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study 159
Iperlipoproteinemie e ipolipoproteinemie 145
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 144
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 132
Acidi Grassi 131
Short term effect of four different macronutrient oral loads on metalbolic profile and flow mediated vasodilatation in healthy young men 131
Dyslipidemias in the older subject: features, significance and treatment dilemmas 130
Dyslipidemia in peripheral vascular disease 130
Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers 129
Disordini del metabolismo delle lipoproteine 127
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia 126
Simvastatin, transdermal patch and oral estrogen-progestin preparation in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial 125
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes 125
Reversible hyperthyroidism and cardiomyopathy caused by consumption of iodocasein 122
Consensus Document on substitution therapy with DHEA in the elderly 122
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 122
The anti-atherogenic properties of HDL particles 121
Bilateral strio-pallido-dentate calcinosis (Fahr's disease): Report of seven cases and revision of literature 121
Flow-Mediated dilation, carotid wall thickness and hdl function in subjects with hyperalphalipoproteinemia 120
Endothelial function and postprandial lipemia 120
Analbuminaemia: a natural model of metabolic compensatory systems 117
Cor Pulmonale 117
Chonobiological analysis of sudden death observed in an emergency department 114
null 114
Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis 113
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 113
Pharmacotherapy of dyslipidemias in the adult population 112
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society 112
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men 111
Advanced diagnostic support in lipidology project: Role for phenotypic and functional evaluation of lipoproteins in dyslipidemias 111
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study) 110
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - A post-hoc analysis of a Phase 3, single-arm, open-label trial 110
Iperchilomicronemia: Patologia negletta dagli internisti? [Hyperchylomicronemia: a neglected disease?] 108
Transient massive hyperlipidaemia in a type 2 diabetic subject. 107
Role of antioxidants in atherosclerosis: Epidemiological and clinical update 106
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 105
Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia 104
Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD) 101
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 99
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort 99
Plasma lipoproteins in soy-treated postmenopausal women: a double-blind,placebo-controlled trial 97
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study 97
Hormonal Replacement Therapy and Lipids: Is Transdermal Norethisterone Acetate Better Than Oral Medroxyprogesterone Acetate? 95
Approccio cronobiologico alla colica renale 95
null 93
Low-dose simvastatin treatment in patients with moderate-grade familial hypercholesterolemia 93
Circadian periodicity in suicidal behaviour and in opiate overdose syndrome 89
null 87
Hypercholesterolemia and the ageing subject. 87
Chronobiology of symptomatic supraventricular paroxysmal tachycardia 83
Lipoproteine e dislipoproteinemie. 83
Lipoproteine 82
Adverse haematological effects of ticlopidine. A report of four cases 81
Effects of soy on lipoproteins in postmenopausal women: a double blind multicentre, placebo-controlled trial. 75
Raggiungimento del target terapeutico nei soggetti avviati al trattamento con statine in pratica clinica. Risultati dallo studio STAR (Statins Target Assessment in Real practice) 75
The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism 72
Menopausal status, dyslipidemia and thyroid function: a cross sectional study. 69
Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree 68
Iperlipoproteinemie e ipolipoproteinemie 67
Profilo lipidico plasmatico, marcatori di infiammazione e arteriopatia periferica degli arti inferiori: lo studio InCHIANTI 66
Secondary prevention of myocardial infarction and long-term adherence to statin therapy: data from the Alarm2 investigation 66
Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: The GAUSS-3 randomized clinical trial 66
Testosterone replacement, cardiovascular system and risk factors in the aging male 64
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease 64
Oli di pesce 57
Stato di salute e disabilità: risultati di una esperienza di valutazione geriatrica in una RSA 52
Lipid abnormalities in patients with extracoronary arteriosclerosis 49
Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol-3-phosphate dehydrogenase 1 deficiency 45
null 44
Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case-control study 39
I trial clinici sull'uso delle statine nella cardiopatia ischemica 38
LIPOPROTEINA (A) E RISCHIO DI MORTE PER TUTTE LE CAUSE IN SOGGETTI ANZIANI FREE-LIVING: LO STUDIO InCHIANTI FOLLOW-UP 29
Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial. 29
Hypolipidemic drugs in elderly subjects: Indications and limits 25
Risk of hospitalization for upper gastrointestinal tract bleeding 21
Association between size of Low-Density Lipoprotein Cholesterol and High-Density Lipoprotein Cholesterol particles and cardiovascular events in type 2 diabetes subjects 18
Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia. 16
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 14
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 4
Totale 11.294
Categoria #
all - tutte 39.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.244
Totale 42.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.002 0 0 0 0 0 195 160 173 150 159 98 67
2020/20211.456 117 80 107 165 82 142 57 136 66 180 159 165
2021/20221.423 55 98 81 114 93 100 85 142 111 128 108 308
2022/20231.614 171 88 115 115 224 166 153 130 162 60 134 96
2023/20241.456 87 97 95 82 85 149 151 116 95 144 161 194
2024/20251.183 116 116 183 180 365 223 0 0 0 0 0 0
Totale 11.294